We are live on ! Find out more
RNLX

Renalytix plc American Depositary Shares

Delisted

RNLX was delisted on the 7th of October, 2024.

20 hedge funds and large institutions have $10.4M invested in Renalytix plc American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 3

129% more call options, than puts

Call options by funds: $64K | Put options by funds: $28K

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

31% more capital invested

Capital invested by funds: $7.96M → $10.4M (+$2.45M)

11% more funds holding

Funds holding: 1820 (+2)

Holders
20
Holders Change
+2
Holders Change %
+11.11%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
10
Reduced
3
Closed
4
Calls
$64K
Puts
$28K
Net Calls
+$36K
Net Calls Change
+$32K

RNLX Hedge Fund Activity: Q2 2023 in Review

20 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q2 2023, worth a combined $10.4M — up 31% from $7.96M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RNLX positions and 4 closed out — a net gain of 2 holders — while 10 added to existing stakes and 3 trimmed.

The largest buyer was Pentwater Capital Management, adding an estimated $147K. The largest seller was Citadel Advisors, exiting entirely with an estimated $28.6K sold.

  • 20 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q2 2023, up from 18 in Q1 2023.
  • Funds reported $10.4M of Renalytix plc American Depositary Shares stock for Q2 2023, up 31% quarter-over-quarter.
  • 6 funds opened new Renalytix plc American Depositary Shares positions in Q2 2023 and 4 closed out, a net change of +2 holders.
  • The largest Renalytix plc American Depositary Shares buyer in Q2 2023 was Pentwater Capital Management, an estimated $147K added.
  • The largest Renalytix plc American Depositary Shares seller in Q2 2023 was Citadel Advisors, an estimated $28.6K sold.

Based on aggregated 13F filings for Q2 2023.